Other Stories

S. Korea to set up 250 COVID-19 vaccination centers across the country Updated: 2021-01-22 15:27:09 KST

As the first batch of COVID-19 vaccine doses is expected to arrive in the coming weeks in South Korea, the country's pharmaceutical giant SK Bioscience will be responsible for transporting and handling the vaccines.
The Korea Disease Control and Prevention Agency said on Friday that the company has been selected to be in charge of this process.
Pfizer's vaccines, which need ultra-cold temperatures will be the first batches the company will be transporting followed by AstraZeneca, Jansen, and those from the COVAX facility.
SK Bioscience plans to cooperate with other companies to establish a cold chain system customized for each of these vaccines, and monitor the temperature and delivery route during the transportation.

"Within this month, there will be a government briefing on who will be getting the shots first, and the specific vaccination plans."

Meanwhile, the country plans to set up 250 vaccination centers across the country.
Each of these centers will be able to vaccinate at least 600 and some centers up to 3-thousand people a day.
A center that can vaccinate 3-thousand people will need 110 healthcare workers, including 20 doctors and 40 nurses.
The Ministry of the Interior and Safety said it is currently working with local governments to find spots suitable for distributing the vaccines.
The inoculation sites will be located where it is possible to operate ultra-cold freezers 24/7 to store vaccines.
And they will be set up where it is convenient in terms of transportation, and large enough for visitors to socially distance themselves from one another.
As well as these centers, people will also be able to get the shots at 10-thousand medical centers nationwide.
The Ministry of the Interior and Safety also added that the first vaccines will likely be available before the Lunar New Year holiday, which begins on February 11th.
Bae Eun-ji, Arirang News.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.